Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene-Reference-Cited by-同舟云学术

Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene

Published:2014-07-10 Issue:2 Volume:124 Page:259-262
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Acunzo Mario¹,Romano Giulia¹,Wernicke Dorothee¹,Balatti Veronica¹,Rassenti Laura Z.²,dell’Aquila Marie³,Kipps Thomas J.²,Pekarsky Yuri¹,Croce Carlo M.¹

Affiliation:

1. Departments of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center and Medicine, The Ohio State University, Columbus, OH; and

2. Department of Medicine and

3. Cytogenetic Laboratory, School of Medicine, University of California at San Diego, La Jolla, CA

Abstract

Key Points A new translocation t(2;11)(q22.1;q21) that involves CXCR4 and MAML2 has been described and characterized in CLL.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/2/259/1380662/259.pdf

Reference15 articles.

1. Molecular basis of CLL.;Pekarsky;Semin Cancer Biol,2010

2. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene.;Bullrich;Cancer Res,2001

3. Oncogenes and cancer.;Croce;N Engl J Med,2008

4. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.;Druker;N Engl J Med,2001

5. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug.;Capdeville;Nat Rev Drug Discov,2002

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational CXCR4 inhibitors in early phase development for the treatment of hematological malignancies;Expert Opinion on Investigational Drugs;2024-08-08

2. Rearrangement of KMT2A Characterizes a Subset of Pediatric Parotid Mucoepidermoid Carcinomas Arising Metachronous to Acute Lymphoblastic Leukemia;Fetal and Pediatric Pathology;2023-07-30

3. The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies;European Journal of Pharmacology;2022-04

4. KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up;Pediatric Blood & Cancer;2021-09-22

5. Topoisomerase II-Induced Chromosome Breakage and Translocation Is Determined by Chromosome Architecture and Transcriptional Activity;Molecular Cell;2019-07